Item 1.01 Entry into a Material Definitive Agreement.

Merger Agreement and Plan of Reorganization

On August 17, 2020, Hennessy Capital Acquisition Corp. IV, a Delaware corporation ("HCAC"), HCAC IV First Merger Sub, Ltd., an exempted company incorporated with limited liability in the Cayman Islands and wholly owned subsidiary of HCAC ("First Merger Sub"), HCAC IV Second Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of HCAC ("Second Merger Sub"), and Canoo Holdings Ltd., an exempted company incorporated with limited liability in the Cayman Islands (the "Company"), entered into a merger agreement and plan of reorganization (the "Merger Agreement"), pursuant to which (a) First Merger Sub will be merged with and into the Company (the "First Merger"), with the Company surviving the First Merger as a wholly owned subsidiary of HCAC (the Company, in its capacity as the surviving corporation of the First Merger, is sometimes referred to as the "Surviving Corporation"); and (b) as soon as practicable, but in any event within 10 days following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation will be merged with and into Second Merger Sub (the "Second Merger" and, together with the First Merger, the "Mergers"), with Second Merger Sub being the surviving entity of the Second Merger (Second Merger Sub, in its capacity as the surviving entity of the Second Merger, is sometimes referred to herein as the "Surviving Entity").





Conversion of Securities


Immediately prior to the effective time of the First Merger (the "Effective Time"), the Company will cause each preference share of the Company, par value $0.0001 per share (each, a "Company Preferred Share"), that is issued and outstanding immediately prior to the Effective Time to be automatically converted into a number of ordinary shares of the Company, par value of $0.0001 per share ("Company Ordinary Shares"), at the then-effective conversion rate as calculated pursuant to the second amended and restated memorandum and articles of association of the Company. All of the Company Preferred Shares converted into Company Ordinary Shares will no longer be outstanding and will cease to exist, and each holder of Company Preferred Shares will thereafter cease to have any rights with respect to such securities.

At the Effective Time, by virtue of the First Merger and without any action on the part of HCAC, First Merger Sub, the Company or the holders of any of the following securities:

(a) each Company Ordinary Share (including each Company Ordinary Share subject to


     forfeiture restrictions or other restrictions (each, a "Company Restricted
     Share"), and including Company Ordinary Shares resulting from the conversion
     of Company Preferred Shares described above) that is issued and outstanding
     immediately prior to the Effective Time will be canceled and converted into
     (i) the right to receive the number of shares of common stock of HCAC, par
     value $0.0001 per share designated as Class A common stock ("HCAC Class A
     Common Stock") equal to the Exchange Ratio (as defined below), and (ii) the
     contingent right to receive a number of shares of HCAC Class A Common Stock,
     as described further below (such shares, the "Earnout Shares"), (which
     consideration, collectively, shall hereinafter be referred to as the "Per
     Share Merger Consideration"); provided, however, that each share of HCAC
     Class A Common Stock issued in exchange for Company Restricted Shares will be
     subject to the terms and conditions giving rise to a substantial risk of
     forfeiture that applied to such Company Restricted Shares immediately prior
     to the Effective Time to the extent consistent with the terms of such Company
     Restricted Shares;



(b) each Company Ordinary Share (including the Company Restricted Shares, as


     applicable) and Company Preferred Share (collectively, the "Company Shares")
     held in the treasury of the Company will be cancelled without any conversion
     thereof and no payment or distribution will be made with respect thereto;



(c) each ordinary share of First Merger Sub, par value $1.00 per share issued and

outstanding immediately prior to the Effective Time will be converted into

and exchanged for one validly issued, fully paid and nonassessable share of

common stock, par value $0.0001 per share, of the Surviving Corporation;






  1





(d) each option to purchase Company Ordinary Shares, whether or not vested, that


     is outstanding immediately prior to the Effective Time (each, a "Company
     Option") will be assumed by HCAC and converted into (i) an option to purchase
     shares of HCAC Class A Common Stock (each, a "Converted Option"), and (ii)
     the contingent right to receive a number of Earnout Shares following the
     closing of the Mergers (the "Closing"). Each Converted Option will have and
     be subject to the same terms and conditions (including vesting and
     exercisability terms) as were applicable to such Company Option immediately
     before the Effective Time, except that (A) each Converted Option will be
     exercisable for that number of shares of HCAC Class A Common Stock equal to
     the product (rounded down to the nearest whole number) of (1) the number of
     Company Ordinary Shares subject to the Company Option immediately before the
     Effective Time and (2) the Exchange Ratio; and (B) the per share exercise
     price for each share of HCAC Class A Common Stock issuable upon exercise of
     the Converted Option will be equal to the quotient (rounded up to the nearest
     whole cent) obtained by dividing (1) the exercise price per share of Company
     Ordinary Shares of such Company Option immediately before the Effective Time
     by (2) the Exchange Ratio; and



(e) each award of restricted stock units to acquire Company Ordinary Shares


     (collectively "Company RSUs") that is outstanding immediately prior to the
     Effective Time will be assumed by HCAC and converted into (i) an award of
     restricted share units to acquire shares of HCAC Class A Common Stock (each,
     a "Converted RSU Award"), and (ii) the contingent right to receive a number
     of Earnout Shares following the Closing. Each Converted RSU Award will have
     and be subject to the same terms and conditions (including vesting and
     exercisability terms) as were applicable to such award of Company RSUs
     immediately before the Effective Time, except that each Converted RSU Award
     will represent the right to acquire that number of shares of HCAC Class A
     Common Stock equal to the product (rounded down to the nearest whole number)
     of (A) the number of Company Ordinary Shares subject to the Company RSU award
     immediately before the Effective Time and (B) the Exchange Ratio.



(f) The following terms shall have the respective meanings ascribed to them


     below:



(i) "Exchange Ratio" means the following ratio: the quotient obtained by dividing

(A) the Company Merger Shares (as defined below) by (B) the Company


     Outstanding Shares (as defined below).
. . .


Item 3.02 Unregistered Sales of Equity Securities.

The disclosure set forth above under the heading "Subscription Agreements" in Item 1.01 of this Current Report is incorporated by reference into this Item 3.02. The shares of HCAC Class A Common Stock to be issued in the PIPE in connection with the Closing will not be registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.

Item 7.01 Regulation FD Disclosure.

Attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference is a copy of the joint press release issued August 18, 2020 announcing the Transactions.

Attached as Exhibit 99.2 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference is the investor presentation dated August 2020 (the "Investor Presentation") that will be used by HCAC in making presentations to certain existing and potential stockholders of HCAC with respect to the Transactions.

HCAC and Company management will hold a joint investor conference call on August 18, 2020 at 8:00 a.m. (Eastern time) to discuss the Canoo business and the Transactions. Interested investors and other parties may listen to the joint conference call by dialing (833) 529-0219 (U.S.) and (236) 389-2148 (international callers/U.S. toll) and enter the conference ID number 8571848.

The foregoing Exhibits 99.1, 99.2 and 99.3 and the information set forth therein are being furnished pursuant to Item 7.01 and shall not be deemed to be filed for purposes of Section 18 of the Exchange Act or otherwise be subject to the liabilities of that section, nor shall they be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.





                                  ************



  8





Additional Information About the Transactions and Where To Find It

In connection with the Transactions, HCAC intends to file the Registration Statement with the SEC, which will include a preliminary proxy statement to be distributed to holders of HCAC's common stock in connection with HCAC's solicitation of proxies for the vote by HCAC's stockholders with respect to the Transactions and other matters as described in the Registration Statement, a prospectus relating to the offer of the securities to be issued to the Company's stockholders in connection with the Transactions, and an information statement to the Company's stockholders regarding the Transactions. After the Registration Statement has been filed and declared effective, HCAC will mail a definitive proxy statement and other relevant documents to its stockholders as of the record date established for voting on the Transactions. HCAC's stockholders and other interested persons are advised to read, once available, the preliminary proxy statement / prospectus and any amendments thereto and, once available, the definitive proxy statement / prospectus, in connection with HCAC's solicitation of proxies for its special meeting of stockholders to be held to approve, among other things, the Transactions, because these documents will contain important information about HCAC, the Company and the Transactions. Stockholders may also obtain a copy of the preliminary or definitive proxy statement/prospectus, once available, as well as other documents filed with the SEC regarding the Transactions and other documents filed with the SEC by HCAC, without charge, at the SEC's website located at www.sec.gov or by directing a request to Nicholas A. Petruska, Executive Vice President, Chief Financial Officer, 3485 North Pines Way, Suite 110, Wilson, Wyoming 83014 or by telephone at (307) 734-4849.

Participants in the Solicitation

HCAC, the Company and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from HCAC's stockholders in connection with the Transactions. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of the Company's stockholders in connection with the Transactions will be set forth in the Company's Registration Statement when it is filed with the SEC. You can find more information about HCAC's directors and executive officers in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 16, 2020. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests will be included in the Registration Statement when it becomes available, which can be obtained free of charge from the sources indicated above.





Forward Looking Statements


This report includes, or incorporates by reference, "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, expectations and timing related to commercial product launches, potential benefits of the Transactions and the potential success of the Company's go-to-market strategy, and expectations related to the terms and timing of the Transactions. These statements are based on various assumptions, whether or not identified in this report, and on the current expectations of the Company's and HCAC's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company and HCAC. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions; the inability of the parties to successfully or timely consummate the Transactions, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the Transactions or that the approval of the stockholders of HCAC or the Company is not obtained; failure to realize the anticipated benefits of the Transactions; risks relating to the uncertainty of the projected financial information with respect to the Company; risks related to the rollout of the Company's business and the timing of expected business milestones and commercial launch; risks related to future market adoption of the Company's offerings; risks related to the Company's go-to-market strategy and subscription business model; the effects of competition on the Company's future business; the amount of redemption requests made by HCAC's public stockholders; the ability of HCAC or the combined company to issue equity or equity-linked securities in connection with the Transactions or in the future, and those factors discussed in HCAC's final prospectus filed on March 4, 2019, Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, in each case, under the heading "Risk Factors," and other documents of HCAC filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither HCAC nor the Company presently know or that HCAC and the Company currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect HCAC's and the Company's expectations, plans or forecasts of future events and views as of the date of this report. HCAC and the Company anticipate that subsequent events and developments will cause HCAC's and the Company's assessments to change. However, while HCAC and the Company may elect to update these forward-looking statements at some point in the future, HCAC and the Company specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing HCAC's and the Company's assessments as of any date subsequent to the date of this report. Accordingly, undue reliance should not be placed upon the forward-looking statements.





  9

Item 9.01 Financial Statements and Exhibits.





 (d) Exhibits




Number                                 Description

2.1*       Merger Agreement and Plan of Reorganization, dated as of August 17,
         2020, by and among Hennessy Capital Acquisition Corp. IV, HCAC IV First
         Merger Sub, Ltd., HCAC IV Second Merger Sub, LLC and Canoo Holdings
         Ltd.

10.1       Form of Shareholder Support Agreement

10.2       Voting and Support Agreement, dated as of August 17, 2020, by and
         among Canoo Holdings Ltd., Hennessy Capital Partners IV LLC and the
         stockholders of Hennessey Capital Acquisition Corp. IV set forth
         therein.

10.3       Form of Subscription Agreement

10.4       Sponsor Warrant Exchange and Share Cancellation Agreement, dated as
         of August 17, 2020, by and between Hennessy Capital Partners IV LLC and
         Hennessy Capital Acquisition Corp. IV.

99.1       Joint Press Release issued August 18, 2020

99.2       Investor Presentation dated August 2020

* Schedules omitted pursuant to Item 601(b)(2) of Regulation S-K. Hennessy

Capital Acquisition Corp. IV agrees to furnish supplementally a copy of any

omitted schedule to the Securities and Exchange Commission upon request.

10

© Edgar Online, source Glimpses